Form D · Biotechnology

Bright Uro, Inc.

Irvine, CA · CIK 0002002648

Offering snapshot reported Sep 5, 2025 · SEC filing

Reported sold
$15M
Offering amount: $15M
Investors reported
35
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Jun 20, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 5, 2025Amendment$14,999,999No comparison35SEC filing
Jul 3, 2025Initial$14,700,754No comparison29SEC filing
Jul 3, 2025Amendment$31,024,760$10,884,966vs May 10, 2024108SEC filing
Sep 23, 2024Amendment$29,289,398$9,149,604vs May 10, 2024155SEC filing
May 10, 2024Amendment$20,139,794$7,176,295vs Dec 5, 2023108SEC filing
Dec 5, 2023Initial$12,963,499No comparison56SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-550727

Source: Form D, filed Sep 5, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Martha Aronson Director
Kurt Azarbarzin Director
Mike Frazzette Director
Michael Frazzette Director
Derek Herrera Director, Executive
Kevin Herschberger Executive
Kevin Hershberger Executive
Sherman Williams Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3 Goddard
Irvine, CA, 92618